Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

LM Medical NYC Expands with Second Clinic Focusing on Cosmetic Plastic Surgery


More about LM Medical NYC:

LM Medical NYC (Facial Plastic Surgery and Dermatology Specialists) is located at 33 Fifth Avenue #1B in New York, NY. As sisters and founders of the practice, Dr. Lesley Rabach, a board-certified facial plastic surgeon, and Dr. Morgan Rabach, a board-certified dermatologist, come together to provide the highest-quality medical, surgical and cosmetic care for patients at one location. This premier NYC practice offers expertise in two fields of medicine to help patients achieve the appearance they desire in a comfortable, upscale atmosphere. The clinic provides many services, ranging from the latest in clinical dermatology treatments to non-invasive cosmetic injections and youthful makeovers with plastic surgery. LM Medical NYC’s new cutting-edge clinic, dedicated for cosmetic plastic surgery, is located at 940 Park Avenue GFRE in New York City. For more information or to schedule a consultation or appointment, please call 212-770-2272, or visit http://www.lmmedicalnyc.com.

Media Contact Dr. Morgan Rabach, LM Medical NYC, 212-770-2272, [email protected], https://lmmedicalnyc.com/

SOURCE LM Medical NYC

Schwartzapfel Lawyers P.C. Secures Justice and Compensation in High-Stakes NYC Construction Cases


Leading New York law firm Schwartzapfel Lawyers P.C. has recovered over sixteen million dollars of compensation for their clients across four recent cases.

NEW YORK, Oct. 30, 2023 /PRNewswire-PRWeb/ — Schwartzapfel Lawyers P.C. is pleased to announce a series of victories in securing justice and compensation for workers in the New York City construction industry. In a commitment to upholding workers’ rights, Schwartzapfel Lawyers P.C. has achieved remarkable results in four recent cases.

First, Schwartzapfel Lawyers P.C. secured a $3,500,000 recovery for a 50-year-old trade union member. This dedicated worker faced perilous conditions while transporting an 80 lb. steel bracket during the construction of a 58-story skyscraper. The resolution provided financial relief and closure.

Next, their legal team secured a $4,250,000 recovery for a dedicated elevator constructor. This worker suffered significant damages and losses due to multiple safety hazards at a billion-dollar construction project. The case is a testament to the need for safety and accountability within the construction industry.

Additionally, the firm secured a pre-trial settlement of $5,240,000 for a union elevator constructor who endured a harrowing ordeal resulting from a failed/defective safety device and suffered serious foot injuries. The case highlights the need for safety standards and reliable equipment.

Finally, Schwartzapfel Lawyers P.C. obtained a $3,770,000 award for an elevator mechanic who suffered severe injuries due to safety code violations in a renowned Manhattan skyscraper’s elevator machine room.

These victories reinforce Schwartzapfel Lawyers P.C.’s commitment to advocating for workers’ rights in the construction industry. Their firm remains dedicated to securing justice for those who have endured hardships while building the vibrant skyline of New York City.

For more information about Schwartzapfel Lawyers P.C., please visit https://www.fightingforyou.com/.

About Schwartzapfel Lawyers P.C.:
Schwartzapfel Lawyers P.C. is a leading law firm dedicated to representing individuals who have suffered personal injuries in New York State. With a track record of success and a commitment to client advocacy, Schwartzapfel Lawyers P.C. has become a trusted name in the legal community. 

Media Contact

Steven J. Schwartzapfel, Schwartzapfel Lawyers P.C., 1 (516) 342-2200, [email protected], https://www.fightingforyou.com/

SOURCE Schwartzapfel Lawyers P.C.

Synterex Named to Inc.’s Second Annual Power Partner Awards


“Trusted B2B partners provide guidance and expertise that founders rely on at various steps of their organization’s journey. Partners that possess a demonstrated ability to deliver quality support are at the core of entrepreneurship and help bring big ideas to life,” says Scott Omelianuk, editor-in-chief of Inc. Business Media.

“We are incredibly thankful to our clients for supporting our business and allowing us to assist them in their mission to get innovative new therapies to patients who need them. It is an honor to be able to participate in such rewarding work and to deliver on our promise to truly serve as an extension of the client’s team,” said Synterex President Jeanette Towles.

Inclusion in Inc.’s Power Partner list marks yet another impressive accomplishment for Synterex, which has been gaining increased recognition for its impactful work in the clinical and regulatory consulting industry. Earlier this year, Synterex made the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. Synterex was also named a Fast 50 company by Boston Business Journal in both 2022 and 2023 and was named the United States Small Business Administration 2022 Home-based Business of the Year for Massachusetts and New England.

To view the complete Power Partners list, go to: https://www.inc.com/power-partner-awards/2023

The November 2023 Issue of Inc. magazine is available online now at https://www.inc.com/magazine and will be on newsstands beginning October 31, 2023.

For more information on Synterex and its leadership, visit: www.synterex.com.

About Inc. Business Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit https://www.inc.com/.

About Synterex, Inc.:

Synterex is a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Delivering quality regulatory documentation requires navigating an evolving landscape influenced by regulators, research committees, healthcare professionals, and—most importantly—the scientific method itself.

At Synterex, we forge lasting and meaningful relationships that flex with the dynamic nature of science and technology.

Media Contact
Jeanette Towles, Synterex, 1 888-760-9906, [email protected], https://synterex.com/

SOURCE Synterex

Face Expert Dr. Robert Morin Joins Exclusive Haute Beauty Network


In addition to successfully performing complex craniofacial reconstructions, Dr. Morin is an expert in a wide range of cosmetic plastic surgery procedures including rhinoplasty, facelift, and breast enhancement. Dr. Morin is extremely passionate about rhinoplasty and he is both a leader and an educator in the field. By combining his expertise in rhinoplasty with his experience as a craniofacial surgeon, Dr. Morin is able to provide exceptional results to patients seeking facial feminization as a part of their gender-affirming surgical care. Dr. Morin also has an exceptional ability to naturally enhance the youthfulness of the face by means of face-lifting and fat grafting, and the aesthetic contour of the body by means of breast augmentation, breast lift, and abdominoplasty.

Dr. Morin’s passion for reconstructing the faces of children led him to co-found a 501c3 charity named Developing Faces. The charity’s mission is to provide high-quality surgical care to babies and children with facial abnormalities living in developing countries around the world. Through his organization and others, Dr. Morin has provided surgical care to children in Guatemala, Colombia, the Philippines, and Mauritius. In addition, he was one of the first surgeons on the ground in Haiti after the devastating earthquake in 2010.

Whether he is in the United States or abroad, Dr. Morin’s mission is to provide all of his patients with the highest quality of surgical care and the best outcomes possible.

Learn more about Dr. Robert Morin by visiting: https://hauteliving.com/hautebeauty/member/robert-morin-md/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

Breast Expert Dr. Josh Waltzman Joins Exclusive Haute Beauty Network


Dr. Waltzman is active in influential research within the field of Plastic Surgery. He has written book chapters and has published his research in various prestigious medical journals. Dr. Waltzman has been invited to present his research to other Plastic Surgeons at numerous national and international meetings.

As a native Southern Californian, Dr. Waltzman is thrilled to return home to the California sun. Having been trained on the West Coast, East Coast, and Midwest, he is excited to bring the best techniques from across the country back to Southern California. Dr. Waltzman is honored to be part of the Long Beach and Orange County medical communities and is committed to the well-being, comfort, and happiness of his patients.

Learn more about Dr. Josh Waltzman by visiting: https://hauteliving.com/hautebeauty/member/dr-josh-waltzman/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

EmeritusDX appoints Dr. Vincent Funari, Renowned Genomics and Bioinformatics Expert, as Chief Scientific Officer


Dr. Funari’s impressive 20-year career has centered on integrating genomic technologies into precision medicine, particularly concerning hematologic and solid tumors. He is licensed as a Clinical Genetic Molecular Biologist Scientist (CGMBS) by the California Department of Health Care Services.

Robert Embree, Chief Executive Officer of EmeritusDX, expressed the company’s excitement: “EmeritusDX is thrilled to have such a well-respected genomics authority like Dr. Funari leading our research and innovation teams. Dr. Funari will be a vital member of the executive team, leveraging years of research expertise, clinical genomics experience, a strong network, and a passion for innovation in precision medicine.”

Upon accepting the role, Dr. Funari commented, “I am thrilled and honored to join the EmeritusDX team and be a part of an organization focused on providing first-in-class patient care. We will work diligently to offer a complete and robust menu for the entire cancer care continuum. I am extremely excited to deploy cutting-edge technology to impact the patients with cancer that EmeritusDX serves.”

About EmeritusDX

EmeritusDX is a cancer diagnostic and information company. Our expertise is in delivering actionable clinical information. Within our world-class laboratory, we perform testing that guides the diagnosis and treatment of cancer patients. Our partners include hospital and private pathology laboratories, biotechnology companies, academic institutions, contract research and pharmaceutical development organizations, and more. We understand the dependency on our accurate and timely results and our commitment to excellence in this regard is unwavering.

If you would like more information about this topic, please call 800-959-2846 or email [email protected]

SOURCE EmeritusDX

Unique Sourcing Solutions to Optimize Time and Budget in Clinical Trial, Upcoming Webinar Hosted by Xtalks


This webinar will introduce innovative sourcing strategies for commercially available medications while assessing the pros and cons of the different options. The speaker will provide insight into key considerations when choosing the appropriate sourcing option(s) and discuss the value of migrating from a transactional approach to strategic sourcing.

The featured speaker will address sponsors’ common concerns when establishing a global clinical trial supply strategy, and provide solutions to challenges that sponsors have faced related to clinical supplies, including:

  •     The cost of wasted material
  •     Medication shortages
  •     Escalating prices of comparators
  •     Increasing complexity of clinical trial designs
  •     Managing short expiry dates
  •     Patient recruitment

Join this webinar to find out more about overcoming these challenges and learn how making the right strategic sourcing choice(s) can have a positive impact on clinical trials as well as the budget.

Join Michelle Novak, Director Business Development, North America, Clinical Trial Services, Inceptua, for the live webinar on Friday, November 10, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Unique Sourcing Solutions to Optimize Time and Budget in Clinical Trial.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected] 

SOURCE Xtalks

Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies, Upcoming Webinar Hosted by Xtalks


With a mission to generate the data and insights required to accelerate the diagnosis and management of CNS disorders for millions of patients and caregivers around the world, Cumulus Neuroscience is advancing an AI-based, multi-domain digital biomarker platform to enable better, faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Designed for and with 10 of the world’s leading pharma companies, the platform enables decentralized trials and is already making a difference in the development of therapies for Alzheimer’s Disease, schizophrenia and treatment-resistant depression.

Designed to provide an industry-wide standard for real-world measurement of disease progression, Cumulus combines patented technology, in-house expertise and key industry partnerships to capture large amounts of real-world, clinical data repeated over time, across multiple behavioral and physiological domains in the patient’s home — all with an electroencephalogram (EEG) headset synced to a novel, tablet-based neuro-assessment platform. Together with machine learning (ML) analytics and the world’s largest database of annotated, longitudinal, neurofunctional data, Cumulus simplifies and improves the robustness of neuroscience clinical trials to provide the best and most cost-effective assessment of CNS treatment outcomes.

Join Brian Murphy, PhD, co-founder and Chief Scientific Officer, Cumulus Neuroscience; and CJ Barnum, PhD, VP of CNS Development, INmune Bio, Inc., for the live webinar on Friday, November 10, 2023, at 12pm EST ( 9am PT).

For more information, or to register for this event, visit Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected] 

SOURCE Xtalks

Ideal Option Opens Addiction Medicine Clinic in Fayetteville


The clinic expands access to in-person medication-assisted treatment for fentanyl, xylazine, meth, heroin, alcohol and other substances in Washington County.

FAYETTEVILLE, Ark., Oct. 30, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in outpatient treatment for addiction to fentanyl, xylazine, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Fayetteville. The newly established low-barrier clinic, conveniently located at 225 N East Ave, is dedicated to offering evidence-based treatment to help individuals reclaim their lives.

Despite a decline in opioid prescribing and heroin use, Arkansas continues to experience a surge in overdose deaths, largely attributed to the widespread presence of fentanyl in the illicit drug market. According to the Arkansas Take Back Opioid Dashboard, overdose deaths in Washington County alone jumped 79% from 14 fatalities in 2020 to 25 in 2021.

The dangerous practice of mixing fentanyl with other illicit substances to intensify addiction, often unbeknownst to the user, has made polysubstance use disorder the prevailing diagnosis at Ideal Option. Their 2022 Annual Patient Outcomes Report, which aggregates lab testing results from over 1,000 patients in Arkansas, reveals that more than 50% of patients tested positive for multiple substances upon enrollment, with 24% testing positive for three or more.

The report does offer hope, however, by underscoring the effectiveness of medication-assisted treatment in combating both isolated and polysubstance use. For patients who remained in Ideal Option’s care throughout 2022, lab testing results show remarkable reductions in substance use:

  • 87% less total opioid use
  • 94% less fentanyl use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic is Ideal Option’s second location in Washington County and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine for 11 years, using buprenorphine-based medications such as Suboxone®, and currently operates 90 clinics across 9 states.

“I have lived in Northwest Arkansas my entire life and am honored to be a part of an amazing treatment team that is having major positive impacts in the lives of individuals who have been affected by substance use disorder,” said Ashley Lahue, peer outreach specialist for Ideal Option. “Our community has made great strides in ending the stigma surrounding addiction by embracing harm reduction efforts and medication-assisted treatment, but we still have a long way to go. I am proud to be a part of an organization that’s leading that effort.”

The new outpatient clinic in Fayetteville is open Monday – Thursday,‥7:30‥a.m. –‥6‥p.m. at 225 N East Ave.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, xylazine, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting‥www.idealoption.com.‥‥

About Ideal Option‥

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped‥more than 70,000 patients through a network of 90 office-based‥medication-assisted treatment (MAT) clinics across 9 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are‥also‥available.‥

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.‥

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.‥

Media Contact

Olivia Roe, Ideal Option, 1 9199466644, [email protected], www.idealoption.com

Twitter, Facebook, LinkedIn

SOURCE Ideal Option



The Plastic Surgery Foundation Appoints Scot Bradley Glasberg, MD, FACS, New President


A private practitioner in New York City, Dr. Glasberg is the first in private practice to lead the Foundation since 2006. Dr. Glasberg performs procedures across the wide spectrum of cosmetic and reconstructive surgery, with a particular interest and focus on breast reconstruction, cosmetic surgery of the breast and body, wound healing, and regenerative medicine. He is board certified by the American Board of Plastic Surgery and the American Board of Surgery.

A past president of ASPS, Dr. Glasberg has served in numerous leadership positions within the Society and Foundation, including ASPS/PSF vice president of development, vice president of Advocacy and Health Policy, vice president of Finance and Treasurer, and chair of the ASPS Government Affairs Council, Council of State Affairs and Political Action Committee (PlastyPAC). Dr. Glasberg is also active in the health policy arena, traveling to Washington D.C. and Albany several times each year to speak to various healthcare and medicolegal issues. Dr. Glasberg has also testified before Congressional committees and panels of the Food and Drug Administration (FDA).

Widely accredited, Dr. Glasberg published articles in multiple peer-reviewed journals, including Plastic and Reconstructive Surgery, where he has shared insights on new techniques in breast reconstruction, breast implant safety, treatment and prevention of keloid and hypertrophic wound healing, and the assessment of pediatric craniofacial deformities, among other topics.

Dr. Glasberg also frequently appears in the news and media and has been featured as an expert on the “CBS Early Show,” “Today Show” (NBC), “Good Morning America” (ABC), the “Paula Zahn Show” (CNN) and the “Morning Show” (WB). He has also been featured on both a national and local level on NBC, CBS, ABC, WB and CNN and has been quoted often in major newspapers such as The New York Times and The Wall Street Journal.

Dr. Glasberg is the recipient of several awards in the specialty, including The PSF’s Distinguished Service Award and the ASPS President’s Award for his work within the society. He also received the Resident and Fellows Award of the Northeastern Society of Plastic Surgeons, Best Presentation at the annual meeting of the New York Society of Cleft Palate/Craniofacial Centers, plus a prize for best paper at the annual meeting of the Connecticut Chapter of the American College of Surgeons.

A graduate of Columbia University in New York, Dr. Glasberg earned his medical degree and graduated with honors from the New York University School of Medicine. He completed his General Surgery training at the University of Connecticut and completed a research fellowship in Craniofacial Surgery at the Institute of Reconstructive Plastic Surgery of the New University Medical Center. He finished his training in the plastic surgery residency at the State University of New York Health Sciences Center.

About The Plastic Surgery Foundation
The Plastic Surgery Foundation (The PSF), founded in 1948, supports research, international volunteer programs and visiting professor programs. The foundation’s mission is to improve the quality of life of patients through research and development. The PSF accomplishes its mission by providing invaluable support to the research of plastic surgery sciences through a variety of grant programs. The PSF works in concert with the American Society of Plastic Surgeons (ASPS).

About American Society of Plastic Surgeons

The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
###

Media Contact

Niccole Caan, American Society of Plastic Surgeons, 847-228-3333, [email protected], www.plasticsurgery.org

SOURCE American Society of Plastic Surgeons